Bristol-Myers Squibb Co. (NYSE:BMY)

Reported net earnings attributable to Bristol-Myers Squibb exhibited volatility over the five-year period. Initial values of approximately $6.994 billion and $6.327 billion in 2021 and 2022, respectively, were followed by an increase to $8.025 billion in 2023. A substantial loss of approximately $8.948 billion was recorded in 2024, before recovering to a profit of $7.054 billion in 2025. The adjusted net earnings attributable to Bristol-Myers Squibb mirrored this pattern closely, with minimal differences from the reported figures.

Net Earnings Trend

The period began with relatively stable earnings, followed by growth in 2023. The significant loss in 2024 represents a substantial deviation from prior performance, and the subsequent recovery in 2025, while positive, did not fully restore earnings to pre-2024 levels. The consistency between reported and adjusted net earnings suggests that adjustments related to mark-to-market available-for-sale securities had a limited impact on the overall net earnings trend.

Adjustment Impact

The difference between reported and adjusted net earnings remained consistently small across all periods. In 2021, the adjustment was -$9 million, in 2022 it was -$2 million, in 2023 it was $2 million, and in 2024 and 2025 it was $0 million. This indicates that mark-to-market adjustments for available-for-sale securities did not materially alter the reported net earnings figures. The adjustments were relatively insignificant in magnitude compared to the overall earnings or loss experienced in each year.

Overall, the financial performance demonstrated considerable fluctuation, particularly with the large loss experienced in 2024. The adjustments to net earnings related to available-for-sale securities were consistently minor and did not appear to be a primary driver of the observed earnings volatility.

The period under review demonstrates considerable fluctuation in profitability ratios, with a notable outlier in the 2024 reporting year. Reported and adjusted profitability metrics exhibit nearly identical values across all periods, suggesting that mark-to-market adjustments for available-for-sale securities have a minimal impact on the overall profitability picture. However, the significant negative values observed in 2024 warrant detailed examination.

Net Profit Margin

Both reported and adjusted net profit margins show relative stability between 2021 and 2023, ranging from approximately 13.7% to 17.8%. A substantial decline is evident in 2024, with both metrics registering a negative value of -18.53%. The final year, 2025, shows a recovery to 14.64%, though remaining below the levels observed in 2021-2023.

Return on Equity (ROE)

Similar to the net profit margin, reported and adjusted ROE values are closely aligned. ROE increases from 19.46% in 2021 to 27.27% in 2023, indicating improving returns to shareholders. The 2024 period experiences a dramatic decrease, resulting in a negative ROE of -54.78%. A strong rebound occurs in 2025, with ROE reaching 38.19%, exceeding prior levels. This volatility suggests significant shifts in equity or net income.

Return on Assets (ROA)

Reported and adjusted ROA follow a comparable pattern to ROE. ROA increases steadily from 6.40% in 2021 to 8.43% in 2023, demonstrating improved asset utilization. A substantial decline is observed in 2024, with ROA falling to -9.66%. The final year, 2025, shows a partial recovery to 7.83%, but remains below the 2023 peak. The negative ROA in 2024 indicates that assets generated a loss during that period.

The consistent alignment between reported and adjusted ratios suggests that changes in the fair value of available-for-sale securities do not materially alter the overall profitability assessment. The pronounced negative performance in 2024 across all three ratios—net profit margin, ROE, and ROA—indicates a significant adverse event impacting the company’s financial performance during that year. The subsequent recovery in 2025, while notable, does not fully restore the profitability levels seen in the 2021-2023 timeframe.

The period under review demonstrates considerable fluctuation in profitability metrics. Reported and adjusted net earnings exhibit similar patterns, suggesting that adjustments made to net earnings do not significantly alter the overall trend. A notable loss is recorded in 2024, followed by a return to profitability in 2025.

Adjusted Net Profit Margin Trend

The adjusted net profit margin begins at 15.06% in 2021 and remains relatively stable at 13.70% in 2022. A substantial increase is then observed in 2023, reaching 17.84%. However, this is followed by a significant decline in 2024, resulting in a negative margin of -18.53%. The margin recovers to 14.64% in 2025, returning to a level comparable to that of 2021 and 2022.

The consistency between reported and adjusted net profit margins indicates that the adjustments applied are not masking underlying performance issues or artificially inflating results. The large negative margin in 2024 warrants further investigation to understand the factors contributing to the loss. The subsequent recovery in 2025 suggests that the issues experienced in 2024 were addressed or were temporary in nature.

Year-over-Year Changes

From 2021 to 2022, the adjusted net profit margin experienced a slight decrease. A significant improvement occurred between 2022 and 2023. The most dramatic change is observed between 2023 and 2024, with a shift from positive to negative profitability. Finally, a substantial recovery is seen from 2024 to 2025, bringing the margin back into positive territory.

The volatility in the adjusted net profit margin highlights the sensitivity of profitability to underlying business conditions. The return to a margin of 14.64% in 2025, while positive, does not represent a return to the peak observed in 2023. Continued monitoring of this metric is recommended to assess the sustainability of the recovery.

The period under review demonstrates significant fluctuations in reported and adjusted net earnings, which directly impact return on equity (ROE) calculations. While reported and adjusted net earnings show similar values across the observed years, resulting in nearly identical ROE figures, substantial volatility is evident, particularly in 2024.

Net Earnings Trend

Reported and adjusted net earnings remained relatively stable between 2021 and 2023, fluctuating around the US$6.3 to US$8.0 billion range. However, a substantial loss of approximately US$8.9 billion was recorded in 2024, followed by a recovery to approximately US$7.0 billion in 2025. The consistency between reported and adjusted net earnings suggests that adjustments are not materially altering the core profitability picture.

Reported ROE Analysis

Reported ROE mirrored the earnings trend. It increased from 19.46% in 2021 to 27.27% in 2023, indicating improving profitability relative to equity. The significant loss in 2024 resulted in a negative ROE of -54.78%, reflecting substantial losses against the equity base. A recovery to 38.19% in 2025 suggests a return to profitability, but remains sensitive to earnings fluctuations.

Adjusted ROE Analysis

Adjusted ROE exhibited an identical pattern to reported ROE across all years. This consistency indicates that the adjustments made to net earnings do not significantly impact the overall ROE calculation. The values are nearly indistinguishable from the reported ROE, reinforcing this observation. The same volatility and recovery patterns are observed, with a peak of 27.27% in 2023 and a low of -54.78% in 2024.

The substantial decline in ROE during 2024 warrants further investigation to understand the underlying causes of the significant net loss. The subsequent recovery in 2025 is positive, but the overall period highlights a sensitivity of ROE to earnings volatility. The close alignment between reported and adjusted ROE suggests that the adjustments are not masking any fundamental issues with profitability.

The period under review demonstrates fluctuating performance in reported and adjusted return on assets (ROA). While adjusted and reported net earnings show similar patterns, the ROA figures reveal a period of growth followed by a significant decline and subsequent recovery.

Overall ROA Trend

Both reported and adjusted ROA exhibit a generally consistent trend across the observed years. From 2021 to 2023, a positive trajectory is evident, with ROA increasing from 6.40% to 8.43% (reported) and 6.39% to 8.44% (adjusted). However, 2024 shows a substantial decrease, resulting in a negative ROA of -9.66% for both reported and adjusted figures. A partial recovery is then observed in 2025, with ROA rising to 7.83% (reported) and 7.84% (adjusted).

Net Earnings and ROA Correlation

The fluctuations in ROA closely mirror the changes in net earnings. The increase in ROA from 2021 to 2023 corresponds with rising net earnings. Conversely, the sharp decline in ROA in 2024 aligns with a substantial net loss. The subsequent improvement in ROA in 2025 is associated with a return to net earnings.

Adjusted vs. Reported ROA

The difference between adjusted and reported ROA is minimal throughout the period. The values are nearly identical in each year, suggesting that adjustments to net earnings have a limited impact on the overall ROA calculation. This indicates that the primary driver of ROA changes is the underlying net earnings performance.

The significant negative ROA in 2024 warrants further investigation to understand the factors contributing to the substantial net loss. While a recovery is seen in 2025, the ROA remains below the peak levels achieved in 2023.